From: Hydrochlorothiazide use, sun exposure, and risk of keratinocyte cancer
Keratinocyte Cancera | |
---|---|
Age (linear years) | 0.60 (0.33, 1.09), p = 0.091 |
Age (spline) | 1.96 (1.11, 3.47), p = 0.020 |
Charlson comorbidity score (points) | 1.18 (1.06, 1.32), p = 0.003 |
Time in cohort before index date (years) | 1.00 (0.98, 1.03), p = 0.689 |
Hydrochlorothiazide duration (years) | 1.14 (1.11, 1.18), p < 0.001 |
Sun exposure | |
High | 1.16 (0.71, 1.48), p = 0.563 |
Low | –- ref –- |
Interaction | 1.02 (0.97, 1.09), p = 0.643 |
Hydrochlorothiazide duration × High sun exposure | 1.16 (1.10, 1.23) |
Hydrochlorothiazide duration × Low sun exposure | 1.14 (1.11, 1.18) |